Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-24

Clinical Trial Update: Comparison of Postoperative Anti-nausea and Vomiting Effect Between Glycopyrronium and Ondansetron [Phase 4]

View source ↗

Summary

Phase 4 trial comparing postoperative anti-nausea and vomiting effects of glycopyrronium vs. ondansetron.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)
  • glycopyrronium (glycopyrronium)

Snippet

Sponsor: The Second Affiliated Hospital of Chongqing Medical University | Conditions: Postoperative Nausea and Vomiting | Phase 4 | Status: UNKNOWN